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Abstract
Many cell biological pathways exhibit overall polarity (net movement of molecules in one direction)
even though individual molecular interactions in the pathway are freely reversible. The A2 RNA
trafficking pathway exhibits polarity in moving specific RNA molecules from the nucleus to
localization sites in the myelin compartment of oligodendrocytes or dendritic spines in neurons.
The A2 pathway is mediated by a ubiquitously expressed trans-acting trafficking factor (hnRNP A2)
that interacts with a specific 11 nucleotide cis-acting trafficking sequence termed the A2 response
element (A2RE) found in several localized RNAs. Five different molecular partners for hnRNP A2
have been identified in the A2 pathway: hnRNP A2 itself, transportin, A2RE RNA, TOG (tumor
overexpressed gene) and hnRNP E1, each playing a key role in one particular step of the A2
pathway. Sequential interactions of hnRNP A2 with different molecular partners at each step
mediate directed movement of trafficking intermediates along the pathway.
Specific "rules of engagement" (both and, either or, only if) govern sequential interactions of hnRNP
A2 with each of its molecular partners. Rules of engagement are defined experimentally using three
component binding assays to measure differential binding of hnRNP A2 to one partner in the
presence of each of the other partners in the pathway. Here we describe rules of engagement for
hnRNP A2 binding to each of its molecular partners and discuss how these rules of engagement
promote polarity in the A2 RNA trafficking pathway.
For molecules with multiple binding partners, specific rules of engagement govern different
molecular interactions. Rules of engagement are ultimately determined by structural relationships
between binding sites on individual molecules. In the A2 RNA trafficking pathway rules of
engagement governing interactions of hnRNP A2 with different binding partners provide the basis
for polarity of movement of intermediates along the pathway.
Background
Cell biological processes are mediated by pathways of
interacting macromolecules. Comprehensive understand-
ing of a particular cell biological pathway requires: inven-
tory of all molecules involved in the pathway (including
concentrations and diffusion coefficients); structures of
all macromolecules in the pathway; interactions among
molecules in the pathway (including kinetic constants);
effects of perturbations of individual components of the
pathway; and computational modeling of pathway
behaviour [1]. Many of these requirements can be met
using large scale systematic approaches. Large scale pro-
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teomics initiatives provide comprehensive inventories of
molecules involved in different cell biological pathways.
Large scale structure determination initiatives (X-ray crys-
tallography and NMR) promise to provide detailed struc-
tural information on many individual pathway
components. Large scale interaction screens (yeast two
hybrid, GST pull down) can identify all interacting part-
ners for each component of a pathway. Large scale func-
tional genomics approaches using RNAi inhibition,
antibody inhibition or mutagenesis can be used to knock
out individual components in a pathway. Large scale
modelling of systems of molecular interactions and com-
plicated pathways can be accomplished using computer
programs such as Virtual Cell http://vcell.org/ if quantita-
tive system parameters are provided. These systematic
approaches can provide detailed information about indi-
vidual components and interactions in the pathway.
Many cell biological pathways contain key components
that interact with multiple different molecular partners. In
the overall human protein-protein interaction network
some "hub" proteins have up to 30 different interacting
partners [2]. Such proteins do not generally interact with
all possible molecular partners simultaneously. Instead,
binding interactions are regulated to ensure sequential
binding and orderly progression of intermediates along
the pathway(s). Possible regulatory mechanisms govern-
ing binding interactions include: sequestration of specific
binding partners to particular subcellular compartments
preventing interactions involving those binding partners
in other compartments, post-translational modifications
to specific binding partners altering their binding proper-
ties, and "rules of engagement" governing interactions of
hub proteins with different binding partners. Here we dis-
cuss how rules of engagement regulate cell biological
pathways.
Three general rules of engagement can be defined: both
and, either or, and only if (equivalent to Boolean operators
OR, XOR and AND, respectively). The both and rule states
that A can interact with both B and C, simultaneously (as
well as individually). The either or rule states that A can
interact with either B or C, but not with both simultane-
ously. The only if rule states that A can interact with B only
if C also interacts (this implies a quantitative rather than
absolute difference in binding since A can bind to both B
and C, individually). Rules of engagement have important
implications for computational modelling of cell biologi-
cal pathways. If A can bind either B or C, the model must
include the following reactions: A + B AB  and A + C
AC. However, if A can bind to both B and C, simultane-
ously, the following additional reactions must be
included in the model: AB  +  C ABC  and  AC  +  B
ABC. If A  binds to B only if C also binds, separate
kinetic constants must be specified for A + B AB  and
AC + B ABC. Thus, understanding rules of engagement
is essential for computational modelling of cell biological
pathways.
Rules of engagement have specific implications regarding
binding sites for different partners on the target molecule.
If A binds both B and C simultaneously this implies that A
contains binding sites for both B and C that are independ-
ent of each other. If A binds either B or C, but not both, this
implies either that A contains binding sites for B and C
that overlap so that both molecules compete for the same
site and cannot bind simultaneously (competitive inhibi-
tion), or that binding of B  induces a conformational
change in A that prevents binding to C (non-competitive
inhibition). If A binds B only if C also binds, this implies
that binding of B induces a conformational change in A
that facilitates binding of C. Elucidating the structural
basis for specific rule of engagement will ultimately
require detailed analysis of the binding surfaces on each
molecule. However, in the absence of such detailed struc-
tural data, experimentally determined rules of engage-
ment can provide important insight into relationships
among binding sites on interacting molecules.
In principle, rules of engagement can be determined
experimentally using any three component system where
binding between two components can be quantified in
the presence or absence of the third component. If bind-
ing of A to B is not affected by binding to C, this indicates
that A can interact with both B and C, simultaneously. If
binding of A to B is inhibited by binding to C, this indi-
cates that A can interact with either B or C but not with
both simultaneously. If binding of A to B stimulates bind-
ing to C, this indicates that A can interact with B only if C
also binds. Measuring binding between each pairwise
combination of interacting partners in the presence of
each of the other binding partners generates a table defin-
ing rules of engagement for interactions among different
binding partners.
In the work described here rules of engagement are deter-
mined using fluorescence correlation spectroscopy (FCS)
to measure binding of differentially labelled fluorescent
recombinant proteins in three component binding assays.
In FCS, fluorescent fluctuations that occur as fluorescent
molecules traverse a small (< 1 fl) observation volume are
analyzed by correlation techniques to determine concen-
trations and diffusion times [3]. Autocorrelation analysis
of individual channels separately provides a measure of
the total concentration of each fluorescent molecule.
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Cross correlation analysis of the two channels provides a
measure of the concentration of molecules that interact
with each other. To determine rules of engagement by FCS
the target protein and one specific partner are differen-
tially labelled with fluorophores. Binding is measured by
cross correlation FCS in the presence and absence of each
of the other unlabeled partners. If the unlabeled binding
partner does not affect the amount of cross correlation,
this indicates that the target protein can bind both  the
labelled partner and  the unlabeled partner simultane-
ously. If the unlabeled partner reduces the amount of
cross correlation, this indicates that the target protein
binds either the labelled partner or the unlabeled partner.
If the unlabeled protein increases the amount of cross cor-
relation, this indicates that the target protein binds the
labelled partner only if the unlabeled partner also binds. In
this manuscript we will summarize rules of engagement
for molecules in the A2 RNA trafficking pathway [4].
Detailed description of the FCS experiments used to deter-
mine rules of engagement for specific molecular interac-
tions will be published separately.
Rules of engagement promote polarity in cell biological
pathways by facilitating interactions that mediate move-
ment of intermediates in one direction and inhibiting
interactions that mediate movement in the reverse direc-
tion. Here we will discuss how rules of engagement gov-
erning molecular interactions of hnRNP A2 with different
molecular partners promote polarity in the A2 RNA traf-
ficking pathway [4]. The A2 RNA trafficking pathway tar-
gets specific RNAs to the myelin compartment in
oligodendrocytes or to dendritic spines in neurons, maxi-
mizing expression of the encoded proteins in the subcel-
lular compartment where the RNA is localized and
minimizing ectopic expression elsewhere in the cell. The
key trans-acting factor in the A2 pathway is hnRNP A2,
which binds specifically to an 11 nucleotide cis-acting
sequence (GCCAAGGAGCC), termed the A2RE (hnRNP
A2 response element) found in several localized RNAs.
HnRNP A2 is exported from the nucleus in association
with A2RE RNA as part of an "RNP code" consisting of an
ensemble of specific RNA binding proteins that deter-
mines subsequent processing, trafficking, translation and
degradation of the RNA. As the RNA moves from one
compartment to the next, certain proteins dissociate and
others bind. However, hnRNP A2 remains associated with
A2RE RNA throughout the A2 pathway and plays key roles
at each step in the pathway by binding to a series of differ-
ent molecular partners. The overall pathway can be
decomposed into six steps: nuclear import of hnRNP A2;
binding of hnRNP A2 to A2RE RNA in the nucleus,
nuclear export of hnRNP A2 bound to A2RE RNA; assem-
bly of hnRNP A2::A2RE RNA complexes into large
supramolecular trafficking intermediates termed RNA
granules; bi-directional transport of hnRNP A2::A2RE
RNA granules along microtubules, during which transla-
tion is inhibited; and translation of RNA granules at local-
ization sites (myelin compartment in oligodendrocytes,
dendritic spines in neurons). As shown in figure 1, five
different molecular partners for hnRNP A2 have been
identified in the A2 pathway: hnRNP A2 itself, transportin
1, A2RE RNA, TOG protein and hnRNP E1. Transition of
trafficking intermediates from one step to the next
involves sequential binding of hnRNP A2 to different
molecular partners at each step. Here we show that polar-
ity in the A2 pathway is determined by rules of engage-
ment governing specific interactions of hnRNP A2 with
individual components of the A2 pathway.
Results and Discussion
hnRNP A2 binding to hnRNP A2
HnRNP A2 is a 36 kD RNA binding protein that shuttles
between nucleus and cytoplasm [14], interacting with dif-
ferent partners at each step in the A2 RNA trafficking path-
way [4]. The protein contains two RNA recognition motif
(RRM) domains, followed by a glycine rich domain
(GRD) and an M9 nuclear localization domain [6,8].
Homotypic interaction of hnRNP A2 with itself, mediated
by the GRD, has been demonstrated by yeast two hybrid
analysis [5]. Fluorescence correlation spectroscopy (FCS)
studies indicate that hnRNP A2 forms oligomers (pre-
dominantly tetramers) in solution (apparent Kd ~ 0.1
nM), which implies that each hnRNP A2 molecule con-
tains at least two separate homotypic binding sites, one
mediating association of monomers to form dimers and
one mediating association of dimers to form higher order
aggregates (figure 2). Thus, each hnRNP A2 molecule
interacts with both hnRNP A2 to form dimers and a second
hnRNP A2 to form tetramers, indicating that each hnRNP
A2 molecule contains two separate homotypic binding
sites. In most cells, the concentration of hnRNP A2, deter-
mined by quantitative western blotting, is 1–6 μM in cyto-
plasm, and ~20 fold higher in nucleus [8,18]. At these
concentrations it is likely that most hnRNP A2 in the cell
is present as oligomers, unless binding to other binding
partners prevents oligomer formation.
To determine rules of engagement governing interactions
of hnRNP A2 with itself and with each of the other part-
ners, the oligomeric state of hnRNP A2 in the presence of
each of its different binding partners was analyzed by FCS.
The oligomeric state of hnRNP A2 was not affected by
transportin, A2RE RNA or hnRNP E1, indicating that
hnRNP A2 can interact with both itself and transportin,
A2RE RNA or hnRNP E1. This means that homotypic
binding sites in hnRNP A2 do not overlap with binding
sites for transportin, A2RE RNA or hnRNP E1. However,
addition of subfragments of TOG caused dissociation of
hnRNP A2 oligomers to dimers, indicating that hnRNP A2
dimers bind to either other hnRNP A2 dimers or to sub-BMC Neuroscience 2006, 7(Suppl 1):S3
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fragments of TOG, but not to both simultaneously. This
means that the binding site for TOG on the hnRNP A2
molecule overlaps with one of the homotypic binding
sites.
hnRNP A2 binding to transportin 1
Transportin is a 97 kD karyopherin that mediates nuclear
import of proteins such as hnRNP A2 that contain non-
conventional nuclear localization signals [6]. The M9
nuclear localization signal in hnRNP A2, consisting of
~35 amino acids near the carboxy terminus of the protein,
binds to a cluster of HEAT repeat motifs in the carboxy ter-
minal half of transportin [12]. During translocation of
transportin::hnRNP A2 from cytoplasm to nucleus trans-
portin interacts with nucleoporins in the nuclear pore
complex (NPC). In the nucleus, transportin dissociates
from hnRNP A2 and binds to Ran GTP. Transpor-
tin::RanGTP is then exported from nucleus to cytoplasm
through the NPC [16]. Thus, during nuclear import trans-
portin interacts with both hnRNP A2 and nucleoporins, in
the nucleus transportin interacts with either hnRNP A2 or
RanGTP, and during nuclear export transportin interacts
with  both  RanGTP  and  nucleoporins. The high nuclear
RanGTP concentration favors formation of transpor-
tin::RanGTP in the nucleus, which makes nuclear import
of hnRNP A2 by transportin essentially irreversible. FCS
experiments indicate that hnRNP A2 can bind both other
hnRNP A2 molecules and transportin, simultaneously. It
is not known if hnRNP A2 is transported into the nucleus
as a monomer or as an oligomer. Nor is it known if a sin-
gle transportin molecule is sufficient to translocate an
hnRNP A2 oligomer into the nucleus or whether separate
transportin molecules bind to each hnRNP A2 molecule
in the oligomer during nuclear import.
As discussed in the following section, hnRNP A2 binding
to A2RE RNA inhibits hnRNP A2 binding to transportin,
indicating that hnRNP A2 can bind either A2RE RNA or
transportin, but not both simultaneously. Since the RNA
binding sites in hnRNP A2 are located in the N terminal
portion of the molecule [7] while the transportin binding
site is located near the C terminus [12], the binding sites
Molecular interactions of hnRNP A2 in the A2 RNA trafficking pathway Figure 1
Molecular interactions of hnRNP A2 in the A2 RNA trafficking pathway. Five different molecular partners of hnRNP 
A2 have been identified in the A2 RNA trafficking pathway – hnRNP A2 itself, transportin 1, A2RE RNA, TOG and hnRNP E1. 
Each step of the A2 RNA trafficking pathway is mediated by interaction of hnRNP A2 with a particular partner. Although inter-
actions between hnRNP A2 and each partner are reversible, the overall pathway exhibits polarity.BMC Neuroscience 2006, 7(Suppl 1):S3
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do not overlap in the primary sequence. Binding of A2RE
RNA may cause a conformational change in the hnRNP
A2 protein that interferes with binding of transportin.
Subfragments of TOG also inhibit binding of hnRNP A2
to transportin (data not shown), indicating that hnRNP
A2 can bind either transportin or TOG but not both simul-
taneously. Both transportin and TOG protein contain
multiple clusters of HEAT repeats [9,12]. The hnRNP A2
binding site(s) in TOG has not been identified. However,
since HEAT repeats in transportin bind to the M9 domain
of hnRNP A2 it is possible that HEAT repeats in TOG also
bind to the M9 domain of hnRNP A2. Thus, transportin
and TOG may compete for the same binding site in
hnRNP A2, resulting in binding of hnRNP A2 to either
transportin or TOG but not both. hnRNP E1 does not
affect binding of hnRNP A2 to transportin, indicating that
hnRNP A2 can bind both transportin and hnRNP E1 simul-
taneously.
hnRNP A2 binding to A2RE RNA
In the nucleus, hnRNP A2 dissociates from transportin
and binds to A2RE RNA. Surface plasmon resonance
(SPR) analysis indicates that hnRNP A2 contains two RNA
binding sites – a specific site, which binds to the A2RE
sequence (GCCAAGGAGCC) (apparent Kd ~ 50 nM) and
a non specific RNA binding site (apparent Kd ~ 300 nM)
[7]. Both sites are found in the N terminal portion of the
hnRNP A2 protein in a region consisting of two consensus
RRM domains. Because of the high concentration of
hnRNP A2 in the nucleus, it is possible that each A2RE
RNA molecule interacts with multiple hnRNP A2 mole-
cules both specifically at A2RE sites and non-specifically,
elsewhere on the RNA. Binding of A2RE RNA does not
affect the oligomeric state of hnRNP A2, indicating that
hnRNP A2 can bind both RNA and other hnRNP A2 mole-
cules simultaneously. This means that the RNA binding
sites in hnRNP A2 do not overlap with the oligomeriza-
tion sites.
The effect of transportin on binding of hnRNP A2 to A2RE
RNA has not been determined in vitro. However, in oli-
godendroyctes in culture, hnRNP A2-GFP expressed by
itself is imported efficiently into the nucleus, presumably
through binding to transportin, whereas in the presence
of excess A2RE RNA, hnRNP A2-GFP is retained in the
cytoplasm [8]. This suggests that binding of hnRNP A2 to
A2RE RNA prevents binding to transportin, which means
that hnRNP A2 can bind either A2RE RNA or transportin,
but not both molecules simultaneously. As discussed
above, since binding sites for transportin and A2RE RNA
are physically separated within the hnRNP A2 molecule,
this means that binding one partner (A2RE RNA) induces
a conformational changes in hnRNP A2 that interferes
with binding of the other partner (transportin). The effect
of hnRNP E1 on binding of hnRNP A2 to A2RE RNA also
has not been determined in vitro. However, hnRNP E1 is
co-localized in granules with hnRNP A2 and A2RE RNA,
and hnRNP E1 inhibits translation of A2RE RNA in an
hnRNP A2-dependent manner [18], suggesting that
hnRNP A2 can bind both A2RE RNA and hnRNP E1, simul-
taneously. This means that the RNA binding sites in
hnRNP A2 do not overlap the hnRNP E1 binding site(s).
hnRNP A2 forms oligomers Figure 2
hnRNP A2 forms oligomers. Individual hnRNP A2 molecules form homotypic interactions with other hnRNP A2 molecules 
to generate oligomers.BMC Neuroscience 2006, 7(Suppl 1):S3
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hnRNP A2 binding to TOG protein
Tumor overexpressed gene (TOG) protein is a long (215
kD) filamentous microtuble binding protein [13]. TOG
orthologues in species from yeast to humans are impli-
cated in regulation of microtubule stability during mitosis
[15]. TOG was identified as a binding partner for hnRNP
A2 in a yeast two hybrid screen [9]. In oligodendrocytes
TOG protein is co-localized with hnRNP A2 in A2RE RNA
granules [9]. Sequence comparisons have identified five
clusters of HEAT repeats (helix turn helix motifs) in TOG
protein [15] and secondary structure algorithms predict a
high probability of alpha helical structure throughout the
length of the TOG protein. The TOG sequence can be
divided into seven subfragments corresponding to the five
identified HEAT repeat clusters from the N terminal por-
tion of the protein and two alpha helix rich regions from
the C terminus of the protein. Each subfragment was
cloned, expressed in bacteria and tested for binding to
hnRNP A2 by FCS and in vitro cross-linking. The results
indicate that each of the seven subfragments of TOG binds
to hnRNP A2. This suggests that full length TOG protein
represents a scaffold for binding a linear array of hnRNP
A2 molecules, as illustrated in figure 3. This could provide
the basis for assembly of multiple A2RE RNA molecules
into granules in the A2 pathway.
FCS experiments indicate that binding of individual TOG
subfragments causes dissociation of hnRNP A2 oligomers
to dimers, indicating that each dimer of hnRNP A2 can
bind to either  another dimer of hnRNP A2 to form a
tetramer, or to TOG protein. TOG and transportin appear
to compete for the same binding sites in hnRNP A2, indi-
cating that hnRNP A2 can bind either TOG or transportin.
However, transportin does not cause dissociation of
hnRNP A2 oligomers to dimers the way TOG does, sug-
gesting that the binding sites for transportin and TOG are
not completely congruent. Binding of hnRNP A2 to TOG
is not affected by hnRNP E1, indicating that hnRNP A2
can bind both TOG and hnRNP E1, simultaneously. This
means that the binding sites for TOG and hnRNP E1 do
not overlap.
hnRNP A2 binding to hnRNP E1
hnRNP E1 is a 40 kD RNA binding protein containing
three KH domains [17]. Together with hnRNP K, hnRNP
E1 binds specifically to a cis-acting poly pyrimidine trans-
lation regulation element called DICE, found in several
different translationally regulated RNAs [10]. Binding of
hnRNP E1 and/or hnRNP K to the DICE element in lipox-
ygenase RNA inhibits translation by interfering with
recruitment of the 60S ribosomal subunit. A2RE RNAs are
not known to contain DICE elements. However, hnRNP
E1 binds to hnRNP A2 and is co-localized with hnRNP A2
in A2RE RNA granules in oligodendrocytes. Furthermore,
hnRNP E1 inhibits translation of A2RE RNA in vitro and in
vivo, in an hnRNP A2-dependent fashion, suggesting that
hnRNP A2 bound to A2RE RNA recruits hnRNP E1, which
inhibits translation of the RNA during transport [18].
Binding of hnRNP E1 does not affect the oligomeric state
of hnRNP A2, indicating that hnRNP A2 can bind both
itself and hnRNP E1, simultaneously. Since hnRNP E1 is
co-localized with hnRNP A2 in A2RE granules during
transport, it is likely that hnRNP A2 can bind both A2RE
RNA and hnRNP E1 simultaneously. Binding of transpor-
tin or TOG to hnRNP A2 is not affected by hnRNP E1,
indicating that hnRNP A2 can bind both hnRNP E1 and
TOG or transportin. Thus, rules of engagement for hnRNP
A2 binding to hnRNP E1 are both and with respect to each
of the other hnRNP A2 binding partners, which means
that hnRNP E1 binding sites on hnRNP A2 are independ-
ent of binding sites for each of its other binding partners.
Analysis of binding between subfragments of hnRNP A2
and hnRNP E1 by FCCS indicates that both N and C ter-
minal subfragments of both proteins contain separate
binding sites for the other protein [18]. Since hnRNP A2
can bind to hnRNP E1 through multiple alternative bind-
ing surfaces it is likely that binding sites for each of the
other hnRNP A2 binding partners will be independent of
at least one of the hnRNP E1 binding surfaces, providing
an explanation for the both and rule of engagement gov-
erning binding of hnRNP A2 and hnRNP E1 with respect
to each of the other hnRNP A2 binding partners.
TOG contains multiple hnRNP A2 binding sites Figure 3
TOG contains multiple hnRNP A2 binding sites. The TOG protein is depicted in cyan with identified HEAT repeats in 
red and an NTF2 homology domain in yellow. hnRNP A2 dimers ar shown in light blue. Seven subfragments of TOG protein 
were cloned, each corresponding to a cluster of HEAT repeats or alpha helical domains. Each subfragment of TOG showed 
binding to hnRNP A2. Binding to TOG subfragments caused dissociation of hnRNP A2 oligomers to dimers.BMC Neuroscience 2006, 7(Suppl 1):S3
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Rules of engagement for hnRNP A2 interactions
Rules of engagement for hnRNP A2 molecular interac-
tions are summarized in Table 1. The table contains both
and interactions and either or interactions but does not
contain only if interactions. Most of the interactions in the
table have been analyzed using three component in vitro
binding experiments with bacterially expressed recom-
binant proteins. It is possible that in living cells rules of
engagement are altered by partitioning of specific binding
partners to particular subcellular compartments, post-
translational modifications of specific binding partners or
by binding to other partners, not shown in the table. Nev-
ertheless, rules of engagement determined in vitro provide
important insight into the A2 RNA trafficking pathway. In
the following sections we discuss molecular interactions
of hnRNP A2 at each step in the A2 pathway with a view
to understanding how rules of engagement determine
polarity.
Nuclear import of hnRNP A2
Nuclear import of hnRNP A2 is mediated by transportin
[6]. Movement of transportin::hnRNP A2 through the
NPC is facilitated by transient interactions of transportin
with nucleoporins in the NPC [16]. Most nuclear trans-
port models assume that transportin::hnRNP A2 can
move in either direction through the NPC so that this step
does not have intrinsic polarity. However, the nucleus
contains alternative either or binding partners for both
hnRNP A2 (A2RE RNA) and transportin (RanGTP) so that
if transportin::hnRNP A2 dissociates in the nucleus
hnRNP A2 will likely bind to A2RE RNA and transportin
will likely bind to RanGTP, preventing their reassociation
with each other. HnRNP A2 associated with A2RE RNA
will be exported from the nucleus via the mRNA export
pathway [11] while transportin::RanGTP can move
through the NPC by interaction with nucleoporins. In the
cytoplasm, the GTPase activity of Ran is activated by Ran-
GAP, converting RanGTP to RanGDP, which dissociates
from transportin, freeing it for another round of nuclear
import. Thus, although movement of transportin::hnRNP
A2 through the NPC may lack polarity, overall nuclear
import of hnRNP A2 by transportin has polarity because
either or rules of engagement govern interactions of both
transportin and hnRNP A2 with other binding partners
that are sequestered in the nucleus. Overall polarity of
nuclear import generates a nuclear/cytoplasmic partition
coefficient of ~20:1 for hnRNP A2 [8].
Nuclear export of hnRNP A2
The high concentration of hnRNP A2 in the nucleus
means that most nuclear hnRNP A2 is probably oligo-
meric. Both oligodendrocytes and neurons (and probably
most other cells) express multiple different A2RE RNAs
that are transported by the A2 pathway. Since hnRNP A2
can both oligomerize and bind A2RE RNA simultaneously,
it is likely that in the nucleus each A2RE RNA molecule
associates with multiple hnRNP A2 oligomers (and other
RNP molecules) through specific and non-specific bind-
ing interactions. Since these interactions are governed by
both and rules of engagement they do not contribute to
polarity in the A2 pathway.
The detailed molecular mechanism for nuclear export of
hnRNP A2 oligomers associated with A2RE RNAs has not
been determined but is likely to follow the mRNA export
pathway [11]. When hnRNP A2 oligomers associated with
A2RE RNA reach the cytoplasm they can interact with
TOG protein, which is excluded from the nucleus during
interphase. Interaction with TOG has two consequences
for hnRNP A2. First, hnRNP A2 oligomers are converted
to dimers because hnRNP A2 dimers can bind either to
TOG or to other A2 dimers, but not both. Second, because
TOG is a long filamentous molecule [13] containing a lin-
ear array of hnRNP A2 binding sites, each of which can
bind an hnRNP A2 dimer with associated A2RE RNA,
multiple hnRNP A2::A2RE RNA complexes will be organ-
ized in a linear array by binding to adjacent binding sites
on the TOG protein. This may nucleate granule assembly
and effectively block reuptake of TOG-associated hnRNP
A2 into the nucleus because the TOG::hnRNP A2::A2RE
RNA complex may be too large to pass through the NPC.
Furthermore, since hnRNP A2 can bind either  TOG  or
transportin, but not both, binding to TOG precludes
binding to transportin, which is necessary for nuclear
import. Thus, either or rules of engagement governing
hnRNP A2 binding to TOG and transportin, ensure polar-
ity in nuclear export of hnRNP A2 associated with A2RE
RNA.
Table 1: 
A2 TRN A2RE cTOG E1
A2::A2 both and both and both and either or both and
A2::TRN both and both and either or either or both and
A2::A2RE both and either or both and either or both and
A2::TOG either or either or either or either or both and
A2::E1 both and both and both and both and both andBMC Neuroscience 2006, 7(Suppl 1):S3
Page 8 of 10
(page number not for citation purposes)
Assembly of hnRNP A2::A2RE RNA into granules
The process of granule assembly requires controlled aggre-
gation of RNA and protein components into large
supramolecular assemblies. Each granule contains multi-
ple (up to 30) RNA molecules, cognate RNA binding pro-
teins (hnRNP A2, hnRNP E1), TOG protein, molecular
motors (conventional kinesin and dynein), and compo-
nents of the translational machinery. RNA granules
assemble rapidly (minutes) and appear to be relatively
stable even though individual binding interactions
among granule components are freely reversible. The
explanation for the stability of RNA granules may lie in
the multiplicity of binding interactions of hnRNP A2 and
rules of engagement governing those interactions. Each
hnRNP A2 molecule has multiple potential interactions
including: at least two different homotypic interactions,
specific and non-specific binding sites for A2RE RNA, four
possible binding interactions with hnRNP E1 and seven
different binding interactions with TOG protein. If gran-
ule assembly is considered as molecular aggregation the
rate of assembly is directly proportional to the number of
unoccupied binding sites in the aggregate while the rate of
disassembly is inversely proportional to the number of
occupied binding sites per subunit. For example, a mole-
cule containing two homotypic binding sites can form
aggregate through head-to-tail interactions. However, the
total number of available binding sites for the aggregate
(which determines the rate of aggregation) will never
increase above two, whereas the number of possible sites
for dissociation (which determines the rate of disaggrega-
tion) will increase in proportion to the number of subu-
nits in the aggregate. In other words, subunits with only
two binding sites cannot form very large aggregates. How-
ever, if the number of binding sites per subunit is larger,
the total number of available binding sites per aggregate
will increase with aggregate size. If individual subunits
interact with more than two other subunits in the aggre-
gate the overall dissociation rate will decrease in propor-
tion to the number of interactions formed. Thus,
increasing the number of binding sites per subunit
increases the aggregation rate and decreases the disaggre-
gation rate. By this reasoning, the multiplicity of binding
sites on each hnRNP A2 molecule and the variety of
potential interactions will tend to increase both the rate of
granule assembly and the size and the stability of granules
formed. The exact stoichiometric molecular composition
and size of each granule may vary somewhat depending
upon which particular molecular interactions of hnRNP
A2 occur during the process of granule assembly, intro-
ducing an element of stochasticity in granule assembly.
Transport of granules on microtubules
Each granule contains both plus end (conventional
kinesin) and minus end (cytoplasmic dynein) molecular
motors which drive bi-directional motion along microtu-
bules. NonA2RE RNA granules are retained in the peri-
karyon where the RNA is translated, whereas A2RE RNA
granules are transported to localization sites in the cell
periphery (the myelin compartment in oligodendrocytes,
dendritic spines in neurons) where the RNA is translated.
It is not known whether differential distribution of A2RE
and nonA2RE RNAs is predominantly due to differential
transport on microtubules or to differential capture at
localization sites, or both. In the differential transport
model, the RNA cargo of the granule somehow affects
motor activities associated with the granule to generate
overall movement biased towards either the plus end (for
A2RE RNA granules) or minus end (for nonA2RE RNA
granules) of the microtubule. The basis for differential
regulation of motor activities is not known. In the differ-
ential capture model, granules move bidirectionally in the
dendrites. A2RE RNA granules are captured at specific
localization sites in the myelin compartment of oli-
godendrocytes or at dendrtic spines in neurons, while
nonA2RE RNA granules are either captured at specific sites
in the perikaryon or remain in the perikaryon by default.
The mechanism for differential capture at specific sites is
not known. The basis for polarity in differential localiza-
tion of A2RE RNA versus nonA2RE RNA granules,
whether mediated by differential transport and differen-
tial capture, is not known.
Translation regulation
Translation is suppressed during RNA granule transport
and activated upon granule localization. Translation of
A2RE RNA is suppressed by hnRNP E1, which binds to
hnRNP A2. During red cell differentiation translation of
lipoxygenase RNA is suppressed by hnRNP E1 and hnRNP
K, which block recruitment of the 60S ribosomal subunit.
Translation of lipoxygenase RNA is activated when
hnRNP E1 and K dissociate from the RNA allowing
recruitment of 60S ribosomal subunit and polysome for-
mation. The mechanism of translation suppression dur-
ing transport of A2RE RNA may be similar, since hnRNP
A2 binds to both A2RE RNA and hnRNP E1. Recruitment
of hnRNP E1 to A2RE RNA may be mediated through
binding of hnRNP E1 to hnRNP A2 associated with A2RE
RNA, which could occur in the nucleus, before export of
the RNA to the cytoplasm, ensuring that A2RE RNA is not
translated in the perikaryon prior to localization. When
A2RE RNA granules are localized in the periphery (in the
myelin compartment of oligodendroctyes or in dendritic
spines of neurons) hnRNP E1 dissociates by an unknown
mechanism. In the case of lipoxygenase RNA in red cells,
phosphorylation of hnRNP K causes dissociation. A simi-
lar mechanism may mediate hnRNP E1 dissociation from
A2RE RNA granules. If hnRNP E1 (or hnRNP A2) is phos-
phorylated by a kinase (or other post-translational modi-
fication) localized to the myelin compartment of
oligodendrocytes or dendritic spines of neurons, the rulesBMC Neuroscience 2006, 7(Suppl 1):S3
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of engagement governing binding of hnRNP A2 to A2RE
RNA and hnRNP E1 may be altered resulting in dissocia-
tion of hnRNP E1 from hnRNP A2, allowing recruitment
of 60S ribosomal subunit and formation of polysomes on
A2RE RNA. In this way, translation activation may repre-
sent a polarity step in the A2 pathway mediated by altera-
tion in the rules of engagement governing interaction of
hnRNP A2 with A2RE RNA and hnRNP E1.
Conclusion
The A2 RNA trafficking pathway is mediated by sequential
interactions of hnRNP A2 with five different molecular
partners. Although each interaction in the pathway is
reversible, the overall pathway has polarity because cer-
tain steps in the pathway are rendered irreversible by rules
of engagement governing interaction of hnRNP A2 with
specific individual molecular partners in the presence of
other partners. Rules of engagement for hnRNP A2 have
been determined experimentally in three component
binding assays. Several interactions of hnRNP A2 are gov-
erned by both and rules, which do not affect polarity,
while, other interactions governed by either or rules gener-
ate polarity by making specific steps in the pathway essen-
tially irreversible. Sequential molecular interaction in the
A2 pathway are outlined in Figure 4. Polarity in other cell
biological pathways containing hub proteins with multi-
Sequential molecular interactions in the A2 pathway Figure 4
Sequential molecular interactions in the A2 pathway. Molecular interactions associated with sequential steps in the A2 
pathway are illustrated. In the first step, newly synthesized hnRNP A2 binds to transportin in the cytoplasm and is imported 
into the nucleus. In the nucleus, transportin binds either RanGTP or hnRNP A2 and hnRNP A2 binds either A2RE RNA or tans-
portin. In the next step, hnRNP A2 oligomers bind to A2RE RNA in the nucleus and are exported to the cytoplasm. In the 
cytoplasm, hnRNP A2 dimers bind either to other hnRNP A2 dimers or to TOG protein, which mediates granule assembly. In 
the next step, hnRNP A2 binds both TOG protein and hnRNP E1, which inhibits translation during transport. In the last step, 
granules bind either hnRNP E1 or ribosomal subunits, to initiate translation. Steps involving either or interactions are essentially 
irreversible and promote polarity to the pathway. Steps involving both and interactions are reversible.Publish with BioMed Central    and   every 
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ple different molecular partners may also reflect rules of
engagement governing different interactions. In such
cases, determining rules of engagement for molecular
interactions of hub proteins may provide important
insight into the basis for polarity.
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